FDA Grants Priority Review To Genentech’s Cancer Immunotherapy TECENTRIQ – Nasdaq
Nasdaq |
FDA Grants Priority Review To Genentech’s Cancer Immunotherapy TECENTRIQ
Nasdaq (RTTNews.com) – Genentech, a member of the Roche Group ( RHHBY ), said that the U.S. Food and Drug Administration has accepted the company’s supplemental Biologics License Application or sBLA and granted Priority Review for TECENTRIQ or atezolizumab … FDA Grants Priority Review to Genentech’s Cancer Immunotherapy TECENTRIQ (Atezolizumab) for Initial Treatment of …Business Wire (press release) Roche’s Tecentriq combination to get speedy FDA reviewReuters |
Chemical & Engineering News |
Controlling CAR-T: How scientists plan to make the engineered T cell therapy safer, and work for more cancers
Chemical & Engineering News CAR T-cell therapy, a treatment that reprograms a person’s immune cells to attack cancer,works wonders for some people with rare blood cancers. But the highly personalized medicine also comes with risks: It can be extremely toxic and, in certain cases … |
Channel NewsAsia |
FDA Grants Priority Review to Genentech’s Cancer Immunotherapy …
Business Wire (press release) SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application … Roche’s Tecentriq combo wins fast FDA review in race to catch rivalsReuters |
Channel NewsAsia |
FDA Grants Priority Review to Genentech’s Cancer Immunotherapy …
Business Wire (press release) SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application … Roche’s Tecentriq combo wins fast FDA review in race to catch rivalsReuters |
Genetic Engineering & Biotechnology News |
25 Up and Coming Gene Therapies
Genetic Engineering & Biotechnology News Additional figures furnished to GEN by Informa show the extent of gene–therapy development: Informa Pharma Intelligence’s Trialtrove database records 729 gene therapies as having been developed, of which nearly two-thirds (461) were preclinical. Those … |
CBC.ca |
More than 400 people register to help Alberta man find stem cell donor
CBC.ca Nguyen’s family organized Sunday’s event to raise awareness for the lack of stem cell donors for ethnic minorities, particularly for people of Asian descent. His sister Susan Nguyen said they never expected that more than 400 people would register as … |
The Homewood-Flossmoor Chronicle |
Homewood man’s life starts anew with stem cell transplant
The Homewood-Flossmoor Chronicle David Matasar will celebrate his 65th birthday on Oct. 17, 2018, but he will tell you his life started over in 2017. The day after his October birthday he will be marking Year One since his stem cell transplant, part of his treatment for mantle cell … |